EcoR1 Capital, LLC
- SEC CIK
- 0001587114
- Latest filing
- Aug 14, 2026
Holdings in Q2 2021
Holdings as of Jun 30, 2021, filed Aug 16, 2021. Long positions only; changes compare share counts with Q1 2021.
- Positions
- 72
- +2 vs. Q1 2021
- Portfolio value
- $2.66B
- +$431.3M (+19.3%) vs. Q1 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PRTAProthena Corp Public Ltd Co | SHS | 11,284,280 | $580.1M | 21.8% | +250,000+2.3% | Added | History |
| MORFMorphic Holding, Inc. | COM | 3,951,566 | $226.8M | 8.5% | +952,251+31.7% | Added | History |
| ANABAnaptysbio, Inc | COM | 7,521,024 | $195.0M | 7.3% | +369,400+5.2% | Added | History |
| XNCRXencor Inc | COM | 4,906,106 | $169.2M | 6.4% | +5,800+0.1% | Added | History |
| RLAYRelay Therapeutics, Inc. | COM | 4,487,776 | $164.2M | 6.2% | +1,058,413+30.9% | Added | History |
| NUVBNuvation Bio Inc. | COM CL A | 13,711,517 | $127.7M | 4.8% | +464,500+3.5% | Added | History |
| STTKShattuck Labs, Inc. | COM | 3,318,410 | $96.2M | 3.6% | +860,151+35.0% | Added | History |
| RCUSArcus Biosciences, Inc. | COM | 3,335,247 | $91.6M | 3.4% | +1,139,355+51.9% | Added | History |
| ALECAlector, Inc. | COM | 4,242,634 | $88.4M | 3.3% | +3,640,034+604.1% | Added | History |
| SPRYARS Pharmaceuticals, Inc. | COM | 2,618,036 | $80.9M | 3.0% | +84,401+3.3% | Added | History |
| KURAKura Oncology, Inc. | COM | 3,724,437 | $77.7M | 2.9% | +31,800+0.9% | Added | History |
| MRTXMirati Therapeutics, Inc. | COM | 464,298 | $75.0M | 2.8% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 3,092,218 | $54.7M | 2.1% | 00.0% | Unchanged | History |
| NRIXNurix Therapeutics, Inc. | COM | 1,967,950 | $52.2M | 2.0% | −51,069−2.5% | Reduced | History |
| Avidity Biosciences, Inc.05370A108 | COM | 2,103,950 | $52.0M | 2.0% | 00.0% | Unchanged | – |
| JANXJanux Therapeutics, Inc. | COM | 1,411,975 | $35.2M | 1.3% | +1,411,975 | New | History |
| SLDBSolid Biosciences Inc. | COM | 9,202,702 | $33.7M | 1.3% | 00.0% | Unchanged | History |
| GRTSGritstone bio, Inc. | COM | 3,421,287 | $31.2M | 1.2% | 00.0% | Unchanged | History |
| Translate Bio, Inc.89374L104 | COM | 1,048,976 | $28.9M | 1.1% | +452,076+75.7% | Added | – |
| ITOSiTeos Therapeutics, Inc. | COM | 1,035,864 | $26.6M | 1.0% | +775,864+298.4% | Added | History |
| EWTXEdgewise Therapeutics, Inc. | COM | 1,224,175 | $26.1M | 1.0% | 00.0% | Unchanged | History |
| KYMRKymera Therapeutics, Inc. | COM | 519,416 | $25.2M | 0.9% | +419,416+419.4% | Added | History |
| DSGNDesign Therapeutics, Inc. | COM | 1,260,019 | $25.1M | 0.9% | +122,079+10.7% | Added | History |
| AKUSAkouos, Inc. | COM | 1,975,984 | $24.8M | 0.9% | 00.0% | Unchanged | History |
| ARVNArvinas, Inc. | COM | 321,724 | $24.8M | 0.9% | +3,020+0.9% | Added | History |
| OVIDOvid Therapeutics Inc. | COM | 6,082,200 | $23.8M | 0.9% | 00.0% | Unchanged | History |
| NGNENeurogene Inc. | COM | 2,358,804 | $21.8M | 0.8% | −763,900−24.5% | Reduced | History |
| ACIUAC Immune SA | SHS | 2,648,163 | $21.0M | 0.8% | −1,000,000−27.4% | Reduced | History |
| BCELAtreca, Inc. | CL A COM | 2,426,685 | $20.7M | 0.8% | 00.0% | Unchanged | History |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 754,545 | $16.8M | 0.6% | +754,545 | New | History |
| KDNYChinook Therapeutics, Inc. | COM | 931,650 | $13.2M | 0.5% | −318,351−25.5% | Reduced | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 200,000 | $10.6M | 0.4% | +200,000 | New | History |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 3,579,377 | $9.56M | 0.4% | +3,579,377 | New | History |
| KRONKronos Bio, Inc. | COM | 387,357 | $9.28M | 0.3% | 00.0% | Unchanged | History |
| BCTG Acquisition Corp05492W103 | COM | 800,000 | $9.10M | 0.3% | 00.0% | Unchanged | – |
| KLRSKalaris Therapeutics, Inc. | COM | 447,012 | $8.82M | 0.3% | 00.0% | Unchanged | History |
| CCCCC4 Therapeutics, Inc. | COM STK | 200,000 | $7.57M | 0.3% | 00.0% | Unchanged | History |
| KRSAKorsana Biosciences, Inc. | COM | 1,606,276 | $6.26M | 0.2% | 00.0% | Unchanged | History |
| VERVVerve Therapeutics, Inc. | COM | 100,000 | $6.03M | 0.2% | +100,000 | New | History |
| SYRSSyros Pharmaceuticals, Inc. | COM | 1,000,000 | $5.45M | 0.2% | 00.0% | Unchanged | History |
| JYACJiya Acquisition Corp. | COM CL A | 500,000 | $4.97M | 0.2% | 00.0% | Unchanged | History |
| ALPNAlpine Immune Sciences, Inc. | COM | 522,635 | $4.70M | 0.2% | −218,655−29.5% | Reduced | History |
| DYNDyne Therapeutics, Inc. | COM | 215,000 | $4.52M | 0.2% | 00.0% | Unchanged | History |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 400,000 | $4.08M | 0.2% | 00.0% | Unchanged | History |
| DNTHDianthus Therapeutics, Inc. | COM | 366,867 | $3.59M | 0.1% | −189,487−34.1% | Reduced | History |
| IGMSIGM Biosciences, Inc. | COM | 38,030 | $3.16M | 0.1% | +38,030 | New | History |
| ODTOdonate Therapeutics, Inc. | COM | 831,200 | $2.90M | 0.1% | +831,200 | New | History |
| NGMNGM Biopharmaceuticals Inc | COM | 143,567 | $2.83M | 0.1% | 00.0% | Unchanged | History |
| FMTXForma Therapeutics Holdings, Inc. | SHS | 105,638 | $2.63M | 0.1% | +105,638 | New | History |
| BOLTBolt Biotherapeutics, Inc. | COM | 150,000 | $2.32M | 0.1% | 00.0% | Unchanged | History |
| BCABBioAtla, Inc. | COM | 50,000 | $2.12M | 0.1% | 00.0% | Unchanged | History |
| BCLS Acquisition CorpG0904B105 | COM CL A | 200,000 | $2.11M | 0.1% | 00.0% | Unchanged | – |
| MLTXMoonLake Immunotherapeutics | COM CL A | 200,000 | $2.07M | 0.1% | 00.0% | Unchanged | History |
| 5 01 Acquisition Corp33836P105 | COM CL A | 200,000 | $1.99M | 0.1% | 00.0% | Unchanged | – |
| Consonance HFW Acquisition CG2445M103 | SHS CL A | 200,000 | $1.99M | 0.1% | +200,000 | New | – |
| Eucrates Biomedical Acqu CorG3141W106 | SHS | 200,000 | $1.97M | 0.1% | 00.0% | Unchanged | – |
| FLACFrazier Lifesciences Acquisition Corp | CL A SHS | 200,495 | $1.96M | 0.1% | +200,495 | New | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 50,000 | $1.71M | 0.1% | 00.0% | Unchanged | History |
| ARYDARYA Sciences Acquisition Corp IV | CL A | 150,000 | $1.61M | 0.1% | 00.0% | Unchanged | History |
| RPTXRepare Therapeutics Inc. | COM | 50,000 | $1.56M | 0.1% | 00.0% | Unchanged | History |
| FS Development Corp II30318F100 | COM CL A | 150,000 | $1.50M | 0.1% | 00.0% | Unchanged | – |
| MGTXMeiraGTx Holdings plc | COM | 94,819 | $1.47M | 0.1% | 00.0% | Unchanged | History |
| CareMax, Inc.14171W111 | *W EXP 06/08/202 | 100,000 | $1.29M | <0.1% | +100,000 | New | – |
| Turmeric Acquisition CorpG9127T108 | CL A | 100,000 | $989.0K | <0.1% | 00.0% | Unchanged | – |
| KNTEKinnate Biopharma Inc. | COM | 25,000 | $582.0K | <0.1% | 00.0% | Unchanged | History |
| Omega Alpha SpacG6749V107 | CL A | 50,000 | $498.0K | <0.1% | 00.0% | Unchanged | – |
| FSTXF-star Therapeutics, Inc. | COM | 46,000 | $395.0K | <0.1% | 00.0% | Unchanged | History |
| Nuvation Bio Inc.67080N119 | *W EXP 07/07/202 | 963,333 | – | – | 00.0% | Unchanged | – |
| Consonance HFW Acquisition CG2445M111 | *W EXP 10/28/202 | 66,665 | – | – | +66,665 | New | – |
| Eucrates Biomedical Acqu CorG3141W122 | *W EXP 10/23/202 | 66,666 | – | – | 00.0% | Unchanged | – |
| Frazier Lifesciences Acqu CoG3710A113 | *W EXP 11/30/202 | 66,665 | – | – | +66,665 | New | – |
| Turmeric Acquisition CorpG9127T124 | *W EXP 10/08/202 | 33,333 | – | – | 00.0% | Unchanged | – |
Sold out since Q1 2021 (11)
Positions held at the end of Q1 2021 that are gone from this filing.
| Security | Class | Shares in Q1 2021 | Value in Q1 2021 | % of portfolio in Q1 2021 | History |
|---|---|---|---|---|---|
| ELDNEledon Pharmaceuticals, Inc. | COM | 1,115,721 | $11.9M | 0.5% | History |
| AMTIApplied Molecular Transport Inc. | COM | 239,443 | $10.5M | 0.5% | History |
| LogicBio Therapeutics, Inc.54142F102 | COM | 688,700 | $5.01M | 0.2% | – |
| WHWKWhitehawk Therapeutics, Inc. | COM | 2,072,782 | $2.67M | 0.1% | History |
| Frazier Lifesciences Acqu CoG3710A121 | UNIT 12/09/2025 | 200,000 | $2.03M | 0.1% | – |
| Consonance HFW Acquisition CG2445M129 | UNIT 99/99/9999 | 200,000 | $1.95M | 0.1% | – |
| CDAKCodiak BioSciences, Inc. | COM | 115,195 | $1.74M | 0.1% | History |
| SNCEScience 37 Holdings, Inc. | COM | 56,500 | $573.0K | <0.1% | History |
| MTCRMetacrine, Inc. | COM | 62,207 | $386.0K | <0.1% | History |
| Deerfield Healthcare Tech Ac244413118 | *W EXP 07/16/202 | 100,000 | – | – | – |
| Vincerx Pharma, Inc.92731L114 | *W EXP 12/24/202 | 150,000 | – | – | – |